amisulpride sandoz 200 amisulpride 200 mg tablet blister pack
sanofi-aventis australia pty ltd - amisulpride -
amisulpride sandoz 100 amisulpride 100 mg tablet blister pack
sanofi-aventis australia pty ltd - amisulpride -
amisulpride 400 winthrop amisulpride 400 mg tablet blister pack
sanofi-aventis australia pty ltd - amisulpride, quantity: 400 mg - tablet, film coated - excipient ingredients: magnesium stearate; sodium starch glycollate type a; peg-40 stearate; lactose monohydrate; titanium dioxide; hypromellose; microcrystalline cellulose - the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.
apo-amisulpride
amisulpride -
pharmacor amisulpride amisulpride 100 mg uncoated tablet blister pack
southern cross pharma pty ltd - amisulpride -
pharmacor amisulpride amisulpride 400 mg uncoated tablet blister pack
southern cross pharma pty ltd - amisulpride -
pharmacor amisulpride amisulpride 200 mg uncoated tablet blister pack
southern cross pharma pty ltd - amisulpride -
apo-amisulpride
apotex nz ltd - amisulpride 400mg; - film coated tablet - 400 mg - active: amisulpride 400mg excipient: basic butylated methacrylate copolymer isopropyl alcohol lactose monohydrate macrogol 6000 magnesium stearate methylcellulose microcrystalline cellulose purified talc purified water sodium starch glycolate titanium dioxide - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.
apo-amisulpride
apotex nz ltd - amisulpride 100mg; - tablet - 100 mg - active: amisulpride 100mg excipient: lactose monohydrate magnesium stearate methylcellulose microcrystalline cellulose sodium starch glycolate - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.
apo-amisulpride
apotex nz ltd - amisulpride 200mg; - tablet - 200 mg - active: amisulpride 200mg excipient: lactose monohydrate magnesium stearate methylcellulose microcrystalline cellulose sodium starch glycolate - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.